Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
切除的非小细胞肺癌新辅助抗PD-1治疗反应的病理特征：定量免疫相关病理反应标准（irPRC）的提议
期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdy218
Cottrell, T R; Thompson, E D; Forde, P M; Stein, J E; Duffield, A S; Anagnostou, V; Rekhtman, N; Anders, R A; Cuda, J D; Illei, P B; Gabrielson, E; Askin, F B; Niknafs, N; Smith, K N; Velez, M J; Sauter, J L; Isbell, J M; Jones, D R; Battafarano, R J; Yang, S C; Danilova, L; Wolchok, J D; Topalian, S L; Velculescu, V E; Pardoll, D M; Brahmer, J R; Hellmann, M D; Chaft, J E; Cimino-Mathews, A; Taube, J M
